Orchid Pharma: Board Meeting Intimation for Approval Of Unaudited Limited Reviewed Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended On September 30 2024

Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 inter alia to consider and approve the Unaudited Limited Reviewed Financial Results (Standalone and Consolidated) of the Company for quarter II and half year ended on September 30 2024 of Financial Year 2024-25.